Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WELL vs GSK✓SelectedUSD · GSKWELL vs GSK performance historyLatest closeAs of+0.61%11/18
Stock and ETF performance explorer

WELL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+222.3%
GSK return
+42.7%
Excess return
+179.7%
Maximum drawdown
-40.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.6%-1.3%+1.9%+0.9%
7D0.0%-3.1%+3.1%+0.7%
30D+6.2%-0.9%+7.1%+6.4%
3M+5.4%-4.2%+9.5%+6.3%
6M+17.1%-1.6%+18.7%+17.3%
YTD+35.1%+2.6%+32.5%+33.7%
1Y+26.5%+6.2%+20.3%+24.2%
3Y+198.5%+55.0%+143.6%+164.2%
5Y+222.3%+42.8%+179.5%+165.9%
All+222.3%+42.7%+179.7%+165.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling